Seeking Alpha

BioCryst (BCRX -4.7%) trades lower today following the announcement that its investigational new...

BioCryst (BCRX -4.7%) trades lower today following the announcement that its investigational new drug BCX4161 has been put on a clinical hold due to manufacturing issues. JMP Securities cut the shares to Market Perform on the news.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|